Fabian Tenenbaum is a seasoned life-science and biotechnology executive with over 20 years of experience in a range of strategic and operational leadership roles. Fabian previously served in various executive positions overseeing drug development, corporate strategy, business development, finance, capital markets and investor relations. Fabian has led a number of successful M&A and IPO transactions in life sciences and has an established track record in building vibrant biotech companies. Fabian joined Nectin Therapeutics in October 2021 as Chief Executive Officer and member of our Board of Directors. Prior to that, Fabian served as the CEO of Bellerophon Therapeutics, CFO and CBO of Anterios Therapeutics (acquired by Allergan PLC) and EVP and CFO of Candela Medical. Fabian is a graduate of the Columbia Business School in New York and the Ben Gurion University Medical School